STOCK COMMENTS / EPS CHANGESAnalog Devices ( ADI) numbers were raised at UBS. Shares are now seen reaching $41. Estimates were also raised at solid P&L discipline amidst uncertainty, UBS said Neutral rating.
Twitter and become a fan on Facebook.
Analysts are most critical about Teva's plan to cut $5 billion in debt by the end of the year.
Teva just isn't 'the people's stock' it used to be.